This study shows for the first time that HIV-1 induces beta-defensin expression in human oral epithelial cells and that beta-defensins block HIV-1 replication via a direct interaction with virions and through modulation of the CXCR4 coreceptor. These properties may be exploited as strategies for mucosal protection against HIV-1 transmission.
Synthetic lethality is a powerful approach to study selective cell killing based on genotype. We show that loss of Rad52 function is synthetically lethal with breast cancer 2, early onset (BRCA2) deficiency, whereas there was no impact on cell growth and viability in BRCA2-complemented cells. The frequency of both spontaneous and double-strand break-induced homologous recombination and ionizing radiation-induced Rad51 foci decreased by 2-10 times when Rad52 was depleted in BRCA2-deficient cells, with little to no effect in BRCA2-complemented cells. The absence of both Rad52 and BRCA2 resulted in extensive chromosome aberrations, especially chromatid-type aberrations. Ionizing radiation-induced and S phase-associated Rad52-Rad51 foci form equally well in the presence or absence of BRCA2, indicating that Rad52 can respond to DNA double-strand breaks and replication stalling independently of BRCA2. Rad52 thus is an independent and alternative repair pathway of homologous recombination and a target for therapy in BRCA2-deficient cells.DNA repair | genetic instability | chromosomal aberrations D NA double-strand breaks (DSBs) are potentially lethal DNA lesions which may arise spontaneously during DNA replication or result from exposure to ionizing radiation or other DNAdamaging agents (1). To repair DSBs, eukaryotes have developed two DSB repair pathways: nonhomologous end joining and homologous recombination (HR) (2). HR is required for the repair of complex double-strand lesions such as crosslinks or one-ended DSBs that occur with a cleaved replication fork; nonhomologous end joining appears to have little role in the repair of these lesions. The absence of Rad51 in proliferating cells (and therefore any measurable HR) results in cell lethality. The loss of function of proteins involved in HR, such as breast cancer 2, early onset (BRCA2), will be viable only if there is a BRCA2-independent pathway for Rad51 function.In Saccharomyces cerevisiae, the Rad52 protein plays a key role in HR (3). However, in vertebrates, knockouts of the Rad52 gene show little phenotype, with no obvious defect in HR. Rad52 knockout mice exhibit a nearly normal phenotype, and Rad52-deficient embryonic stem cells are not hypersensitive to agents that induce DSBs, either simple or complex (4, 5). In contrast, Rad51 knockout is embryonically lethal (6, 7), and depletion of Rad51 from vertebrate cells results in an accumulation of chromosome aberrations and subsequent cell death (8). These findings indicate the essential role of Rad51 in the maintenance of chromosomal DNA during the mitotic cell cycle, but the role for Rad52 in vertebrate cells is unclear.Accumulating evidence implicates BRCA2 as an integral component of the HR machinery via the direct regulation of the assembly of Rad51 filaments and its subsequent activity in strand exchange (9-11). Biochemical studies showed that the Ustilago maydis BRCA2 ortholog, Brh2, is involved in the recruitment of Rad51 to the sites of HR; Rad51 then mediates the displacement of replication protein A...
The pathway determining malignant cellular transformation, which depends upon mutation of the BRCA1 tumor suppressor gene, is poorly defined. A growing body of evidence suggests that promotion of DNA double-strand break repair by homologous recombination (HR) may be the means by which BRCA1 maintains genomic stability, while a role of BRCA1 in error-prone nonhomologous recombination (NHR) processes has just begun to be elucidated. The BRCA1 protein becomes phosphorylated in response to DNA damage, but the effects of phosphorylation on recombinational repair are unknown. In this study, we tested the hypothesis that the BRCA1-mediated regulation of recombination requires the Chk2-and ATM-dependent phosphorylation sites. We studied Rad51-dependent HR and random chromosomal integration of linearized plasmid DNA, a subtype of NHR, which we demonstrate to be dependent on the Mre11-Rad50-Nbs1 complex. Prevention of Chk2-mediated phosphorylation via mutation of the serine 988 residue of BRCA1 disrupted both the BRCA1-dependent promotion of HR and the suppression of NHR. Similar results were obtained when endogenous Chk2 kinase activity was inhibited by expression of a dominant-negative Chk2 mutant. Surprisingly, the opposing regulation of HR and NHR did not require the ATM phosphorylation sites on serines 1423 and 1524. Together, these data suggest a functional link between recombination control and breast cancer predisposition in carriers of Chk2 and BRCA1 germ line mutations. We propose a dual regulatory role for BRCA1 in maintaining genome integrity, whereby BRCA1 phosphorylation status controls the selectivity of repair events dictated by HR and error-prone NHR.The tumor suppressor gene BRCA1 is mutated in up to 50% of cases of familial early-onset breast cancer and in most families with hereditary breast and ovarian cancer (50). BRCA1 is necessary for cellular processes ranging from cell cycle checkpoint control, DNA repair, regulation of transcription, protein ubiquitination, and apoptosis to chromatin remodeling (28,48,54,63). Dysfunction of many or all of these BRCA1 properties may be invoked in cancer development.Of the many types of DNA damage, DNA double-strand breaks (DSBs) represent a particularly dangerous form of damage. If not properly repaired, a DSB causes genetic changes and/or cell death. DSBs can arise spontaneously or may be induced by exogenous DNA damaging agents. The cell utilizes two principal pathways for the repair of DSBs: homologous recombination (HR) and nonhomologous recombination (NHR) (29, 62). Homology-mediated repair requires an undamaged template molecule that contains a homologous DNA sequence ordinarily on a sister chromatid or a homologous chromosome. HR is mediated through multiple proteins, including the Rad51/Rad52 recombinases and BRCA2. Several lines of evidence have indicated a role of BRCA1 in the HR pathway. BRCA1 colocalizes with BRCA2 and Rad51 (10, 41, 52, 70) and forms ionizing radiation (IR)-induced subnuclear foci (IRIF) containing Rad51 protein. Rad51 IRIF are reduc...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.